Staphylococcus epidermidis (Winslow and Winslow) Evans
Strain Designations
SMU 76
Application
Capsular type I, use in MAb production and protection in mice
Isolation
Clinical isolate
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Ichiman Y, et al. Monoclonal IgM antibody protection in mice against infection with an encapsulated strain of Staphylococcus epidermidis. Can. J. Microbiol. 37: 404-407, 1991. PubMed: 1715230
Ohshima Y, et al. Cell surface antigen of encapsulated Staphylococcus epidermidis ATCC 31432. J. Clin. Microbiol. 25: 1338-1340, 1987. PubMed: 3611324